According to this study, over the next five years the Insulin market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Insulin, covering the supply chain analysis, impact assessment to the Insulin market size growth rate in several scenarios, and the measures to be undertaken by Insulin companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Eli Lilly
Tonghua Dongbao
Ganlee
Sanofi-Aventis
United Laboratory
Jiangsu Wanbang
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Insulin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Insulin market by identifying its various subsegments.
Focuses on the key global Insulin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Consumption 2015-2025
2.1.2 Insulin Consumption CAGR by Region
2.2 Insulin Segment by Type
2.2.1 Animal Insulin
2.2.2 Regular Human Insulin
2.2.3 Insulin Analogue
2.3 Insulin Consumption by Type
2.3.1 Global Insulin Consumption Market Share by Type (2015-2020)
2.3.2 Global Insulin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Insulin Sale Price by Type (2015-2020)
2.4 Insulin Segment by Application
2.4.1 Short acting
2.4.2 Intermediate acting
2.4.3 Long acting
2.4.4 Pre-mix Insulin
2.5 Insulin Consumption by Application
2.5.1 Global Insulin Consumption Market Share by Type (2015-2020)
2.5.2 Global Insulin Value and Market Share by Type (2015-2020)
2.5.3 Global Insulin Sale Price by Type (2015-2020)
3 Global Insulin by Company
3.1 Global Insulin Sales Market Share by Company
3.1.1 Global Insulin Sales by Company (2018-2020)
3.1.2 Global Insulin Sales Market Share by Company (2018-2020)
3.2 Global Insulin Revenue Market Share by Company
3.2.1 Global Insulin Revenue by Company (2018-2020)
3.2.2 Global Insulin Revenue Market Share by Company (2018-2020)
3.3 Global Insulin Sale Price by Company
3.4 Global Insulin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Insulin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Insulin by Regions
4.1 Insulin by Regions
4.2 Americas Insulin Consumption Growth
4.3 APAC Insulin Consumption Growth
4.4 Europe Insulin Consumption Growth
4.5 Middle East & Africa Insulin Consumption Growth
5 Americas
5.1 Americas Insulin Consumption by Countries
5.1.1 Americas Insulin Consumption by Countries (2015-2020)
5.1.2 Americas Insulin Value by Countries (2015-2020)
5.2 Americas Insulin Consumption by Type
5.3 Americas Insulin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Insulin Consumption by Regions
6.1.1 APAC Insulin Consumption by Regions (2015-2020)
6.1.2 APAC Insulin Value by Regions (2015-2020)
6.2 APAC Insulin Consumption by Type
6.3 APAC Insulin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Insulin by Countries
7.1.1 Europe Insulin Consumption by Countries (2015-2020)
7.1.2 Europe Insulin Value by Countries (2015-2020)
7.2 Europe Insulin Consumption by Type
7.3 Europe Insulin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Insulin by Countries
8.1.1 Middle East & Africa Insulin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Insulin Value by Countries (2015-2020)
8.2 Middle East & Africa Insulin Consumption by Type
8.3 Middle East & Africa Insulin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Insulin Distributors
10.3 Insulin Customer
11 Global Insulin Market Forecast
11.1 Global Insulin Consumption Forecast (2021-2025)
11.2 Global Insulin Forecast by Regions
11.2.1 Global Insulin Forecast by Regions (2021-2025)
11.2.2 Global Insulin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Insulin Forecast by Type
11.8 Global Insulin Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Information
12.1.2 Insulin Product Offered
12.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk Latest Developments
12.2 Eli Lilly
12.2.1 Company Information
12.2.2 Insulin Product Offered
12.2.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Eli Lilly Latest Developments
12.3 Tonghua Dongbao
12.3.1 Company Information
12.3.2 Insulin Product Offered
12.3.3 Tonghua Dongbao Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Tonghua Dongbao Latest Developments
12.4 Ganlee
12.4.1 Company Information
12.4.2 Insulin Product Offered
12.4.3 Ganlee Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Ganlee Latest Developments
12.5 Sanofi-Aventis
12.5.1 Company Information
12.5.2 Insulin Product Offered
12.5.3 Sanofi-Aventis Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi-Aventis Latest Developments
12.6 United Laboratory
12.6.1 Company Information
12.6.2 Insulin Product Offered
12.6.3 United Laboratory Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 United Laboratory Latest Developments
12.7 Jiangsu Wanbang
12.7.1 Company Information
12.7.2 Insulin Product Offered
12.7.3 Jiangsu Wanbang Insulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Jiangsu Wanbang Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Insulin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Animal Insulin
Table 5. Major Players of Regular Human Insulin
Table 6. Major Players of Insulin Analogue
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Insulin Consumption Market Share by Type (2015-2020)
Table 9. Global Insulin Revenue by Type (2015-2020) ($ million)
Table 10. Global Insulin Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Insulin Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Insulin Consumption Market Share by Application (2015-2020)
Table 14. Global Insulin Value by Application (2015-2020)
Table 15. Global Insulin Value Market Share by Application (2015-2020)
Table 16. Global Insulin Sale Price by Application (2015-2020)
Table 17. Global Insulin Sales by Company (2017-2019) (M Pcs)
Table 18. Global Insulin Sales Market Share by Company (2017-2019)
Table 19. Global Insulin Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Insulin Revenue Market Share by Company (2017-2019)
Table 21. Global Insulin Sale Price by Company (2017-2019)
Table 22. Global Insulin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Insulin Products Offered
Table 24. Insulin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Insulin Consumption by Regions 2015-2020 (M Pcs)
Table 26. Global Insulin Consumption Market Share by Regions 2015-2020
Table 27. Global Insulin Value by Regions 2015-2020 ($ Millions)
Table 28. Global Insulin Value Market Share by Regions 2015-2020
Table 29. Americas Insulin Consumption by Countries (2015-2020) (M Pcs)
Table 30. Americas Insulin Consumption Market Share by Countries (2015-2020)
Table 31. Americas Insulin Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Insulin Value Market Share by Countries (2015-2020)
Table 33. Americas Insulin Consumption by Type (2015-2020) (M Pcs)
Table 34. Americas Insulin Consumption Market Share by Type (2015-2020)
Table 35. Americas Insulin Consumption by Application (2015-2020) (M Pcs)
Table 36. Americas Insulin Consumption Market Share by Application (2015-2020)
Table 37. APAC Insulin Consumption by Countries (2015-2020) (M Pcs)
Table 38. APAC Insulin Consumption Market Share by Countries (2015-2020)
Table 39. APAC Insulin Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Insulin Value Market Share by Regions (2015-2020)
Table 41. APAC Insulin Consumption by Type (2015-2020) (M Pcs)
Table 42. APAC Insulin Consumption Market Share by Type (2015-2020)
Table 43. APAC Insulin Consumption by Application (2015-2020) (M Pcs)
Table 44. APAC Insulin Consumption Market Share by Application (2015-2020)
Table 45. Europe Insulin Consumption by Countries (2015-2020) (M Pcs)
Table 46. Europe Insulin Consumption Market Share by Countries (2015-2020)
Table 47. Europe Insulin Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Insulin Value Market Share by Countries (2015-2020)
Table 49. Europe Insulin Consumption by Type (2015-2020) (M Pcs)
Table 50. Europe Insulin Consumption Market Share by Type (2015-2020)
Table 51. Europe Insulin Consumption by Application (2015-2020) (M Pcs)
Table 52. Europe Insulin Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Insulin Consumption by Countries (2015-2020) (M Pcs)
Table 54. Middle East & Africa Insulin Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Insulin Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Insulin Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Insulin Consumption by Type (2015-2020) (M Pcs)
Table 58. Middle East & Africa Insulin Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Insulin Consumption by Application (2015-2020) (M Pcs)
Table 60. Middle East & Africa Insulin Consumption Market Share by Application (2015-2020)
Table 61. Insulin Distributors List
Table 62. Insulin Customer List
Table 63. Global Insulin Consumption Forecast by Countries (2021-2025) (M Pcs)
Table 64. Global Insulin Consumption Market Forecast by Regions
Table 65. Global Insulin Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Insulin Value Market Share Forecast by Regions
Table 67. Global Insulin Consumption Forecast by Type (2021-2025) (M Pcs)
Table 68. Global Insulin Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Insulin Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Insulin Value Market Share Forecast by Type (2021-2025)
Table 71. Global Insulin Consumption Forecast by Application (2021-2025) (M Pcs)
Table 72. Global Insulin Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Insulin Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Insulin Value Market Share Forecast by Application (2021-2025)
Table 75. Novo Nordisk Product Offered
Table 76. Novo Nordisk Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 77. Novo Nordisk Main Business
Table 78. Novo Nordisk Latest Developments
Table 79. Novo Nordisk Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 80. Eli Lilly Product Offered
Table 81. Eli Lilly Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 82. Eli Lilly Main Business
Table 83. Eli Lilly Latest Developments
Table 84. Eli Lilly Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 85. Tonghua Dongbao Product Offered
Table 86. Tonghua Dongbao Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 87. Tonghua Dongbao Main Business
Table 88. Tonghua Dongbao Latest Developments
Table 89. Tonghua Dongbao Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 90. Ganlee Product Offered
Table 91. Ganlee Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 92. Ganlee Main Business
Table 93. Ganlee Latest Developments
Table 94. Ganlee Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi-Aventis Product Offered
Table 96. Sanofi-Aventis Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 97. Sanofi-Aventis Main Business
Table 98. Sanofi-Aventis Latest Developments
Table 99. Sanofi-Aventis Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 100. United Laboratory Product Offered
Table 101. United Laboratory Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 102. United Laboratory Main Business
Table 103. United Laboratory Latest Developments
Table 104. United Laboratory Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 105. Jiangsu Wanbang Product Offered
Table 106. Jiangsu Wanbang Basic Information, Company Total Revenue (in $ million), Insulin Manufacturing Base, Sales Area and Its Competitors
Table 107. Jiangsu Wanbang Main Business
Table 108. Jiangsu Wanbang Latest Developments
Table 109. Jiangsu Wanbang Insulin Sales (M Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Insulin
Figure 2. Insulin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Insulin Consumption Growth Rate 2015-2025 (M Pcs)
Figure 5. Global Insulin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Animal Insulin
Figure 7. Product Picture of Regular Human Insulin
Figure 8. Product Picture of Insulin Analogue
Figure 9. Global Insulin Consumption Market Share by Type (2015-2020)
Figure 10. Global Insulin Value Market Share by Type (2015-2020)
Figure 11. Insulin Consumed in Short acting
Figure 12. Global Insulin Market: Short acting (2015-2020) (M Pcs)
Figure 13. Global Insulin Market: Short acting (2015-2020) ($ Millions)
Figure 14. Insulin Consumed in Intermediate acting
Figure 15. Global Insulin Market: Intermediate acting (2015-2020) (M Pcs)
Figure 16. Global Insulin Market: Intermediate acting (2015-2020) ($ Millions)
Figure 17. Insulin Consumed in Long acting
Figure 18. Global Insulin Market: Long acting (2015-2020) (M Pcs)
Figure 19. Global Insulin Market: Long acting (2015-2020) ($ Millions)
Figure 20. Insulin Consumed in Pre-mix Insulin
Figure 21. Global Insulin Market: Pre-mix Insulin (2015-2020) (M Pcs)
Figure 22. Global Insulin Market: Pre-mix Insulin (2015-2020) ($ Millions)
Figure 23. Global Insulin Consumption Market Share by Application (2015-2020)
Figure 24. Global Insulin Value Market Share by Application (2015-2020)
Figure 25. Global Insulin Sales Market Share by Company in 2017
Figure 26. Global Insulin Sales Market Share by Company in 2019
Figure 27. Global Insulin Revenue Market Share by Company in 2017
Figure 28. Global Insulin Revenue Market Share by Company in 2019
Figure 29. Global Insulin Sale Price by Company in 2019
Figure 30. Global Insulin Consumption Market Share by Regions 2015-2020
Figure 31. Global Insulin Value Market Share by Regions 2015-2020
Figure 32. Americas Insulin Consumption 2015-2020 (M Pcs)
Figure 33. Americas Insulin Value 2015-2020 ($ Millions)
Figure 34. APAC Insulin Consumption 2015-2020 (M Pcs)
Figure 35. APAC Insulin Value 2015-2020 ($ Millions)
Figure 36. Europe Insulin Consumption 2015-2020 (M Pcs)
Figure 37. Europe Insulin Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Insulin Consumption 2015-2020 (M Pcs)
Figure 39. Middle East & Africa Insulin Value 2015-2020 ($ Millions)
Figure 40. Americas Insulin Consumption Market Share by Countries in 2019
Figure 41. Americas Insulin Value Market Share by Countries in 2019
Figure 42. Americas Insulin Consumption Market Share by Type in 2019
Figure 43. Americas Insulin Consumption Market Share by Application in 2019
Figure 44. United States Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 45. United States Insulin Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 47. Canada Insulin Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 49. Mexico Insulin Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Insulin Consumption Market Share by Countries in 2019
Figure 51. APAC Insulin Value Market Share by Regions in 2019
Figure 52. APAC Insulin Consumption Market Share by Type in 2019
Figure 53. APAC Insulin Consumption Market Share by Application in 2019
Figure 54. China Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 55. China Insulin Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 57. Japan Insulin Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 59. Korea Insulin Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 61. Southeast Asia Insulin Value Growth 2015-2020 ($ Millions)
Figure 62. India Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 63. India Insulin Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 65. Australia Insulin Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Insulin Consumption Market Share by Countries in 2019
Figure 67. Europe Insulin Value Market Share by Countries in 2019
Figure 68. Europe Insulin Consumption Market Share by Type in 2019
Figure 69. Europe Insulin Consumption Market Share by Application in 2019
Figure 70. Germany Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 71. Germany Insulin Value Growth 2015-2020 ($ Millions)
Figure 72. France Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 73. France Insulin Value Growth 2015-2020 ($ Millions)
Figure 74. UK Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 75. UK Insulin Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 77. Italy Insulin Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 79. Russia Insulin Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Insulin Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Insulin Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Insulin Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Insulin Consumption Market Share by Application in 2019
Figure 84. Egypt Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 85. Egypt Insulin Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 87. South Africa Insulin Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 89. Israel Insulin Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 91. Turkey Insulin Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Insulin Consumption Growth 2015-2020 (M Pcs)
Figure 93. GCC Countries Insulin Value Growth 2015-2020 ($ Millions)
Figure 94. Global Insulin Consumption Growth Rate Forecast (2021-2025) (M Pcs)
Figure 95. Global Insulin Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Insulin Consumption 2021-2025 (M Pcs)
Figure 97. Americas Insulin Value 2021-2025 ($ Millions)
Figure 98. APAC Insulin Consumption 2021-2025 (M Pcs)
Figure 99. APAC Insulin Value 2021-2025 ($ Millions)
Figure 100. Europe Insulin Consumption 2021-2025 (M Pcs)
Figure 101. Europe Insulin Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Insulin Consumption 2021-2025 (M Pcs)
Figure 103. Middle East & Africa Insulin Value 2021-2025 ($ Millions)
Figure 104. United States Insulin Consumption 2021-2025 (M Pcs)
Figure 105. United States Insulin Value 2021-2025 ($ Millions)
Figure 106. Canada Insulin Consumption 2021-2025 (M Pcs)
Figure 107. Canada Insulin Value 2021-2025 ($ Millions)
Figure 108. Mexico Insulin Consumption 2021-2025 (M Pcs)
Figure 109. Mexico Insulin Value 2021-2025 ($ Millions)
Figure 110. Brazil Insulin Consumption 2021-2025 (M Pcs)
Figure 111. Brazil Insulin Value 2021-2025 ($ Millions)
Figure 112. China Insulin Consumption 2021-2025 (M Pcs)
Figure 113. China Insulin Value 2021-2025 ($ Millions)
Figure 114. Japan Insulin Consumption 2021-2025 (M Pcs)
Figure 115. Japan Insulin Value 2021-2025 ($ Millions)
Figure 116. Korea Insulin Consumption 2021-2025 (M Pcs)
Figure 117. Korea Insulin Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Insulin Consumption 2021-2025 (M Pcs)
Figure 119. Southeast Asia Insulin Value 2021-2025 ($ Millions)
Figure 120. India Insulin Consumption 2021-2025 (M Pcs)
Figure 121. India Insulin Value 2021-2025 ($ Millions)
Figure 122. Australia Insulin Consumption 2021-2025 (M Pcs)
Figure 123. Australia Insulin Value 2021-2025 ($ Millions)
Figure 124. Germany Insulin Consumption 2021-2025 (M Pcs)
Figure 125. Germany Insulin Value 2021-2025 ($ Millions)
Figure 126. France Insulin Consumption 2021-2025 (M Pcs)
Figure 127. France Insulin Value 2021-2025 ($ Millions)
Figure 128. UK Insulin Consumption 2021-2025 (M Pcs)
Figure 129. UK Insulin Value 2021-2025 ($ Millions)
Figure 130. Italy Insulin Consumption 2021-2025 (M Pcs)
Figure 131. Italy Insulin Value 2021-2025 ($ Millions)
Figure 132. Russia Insulin Consumption 2021-2025 (M Pcs)
Figure 133. Russia Insulin Value 2021-2025 ($ Millions)
Figure 134. Spain Insulin Consumption 2021-2025 (M Pcs)
Figure 135. Spain Insulin Value 2021-2025 ($ Millions)
Figure 136. Egypt Insulin Consumption 2021-2025 (M Pcs)
Figure 137. Egypt Insulin Value 2021-2025 ($ Millions)
Figure 138. South Africa Insulin Consumption 2021-2025 (M Pcs)
Figure 139. South Africa Insulin Value 2021-2025 ($ Millions)
Figure 140. Israel Insulin Consumption 2021-2025 (M Pcs)
Figure 141. Israel Insulin Value 2021-2025 ($ Millions)
Figure 142. Turkey Insulin Consumption 2021-2025 (M Pcs)
Figure 143. Turkey Insulin Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Insulin Consumption 2021-2025 (M Pcs)
Figure 145. GCC Countries Insulin Value 2021-2025 ($ Millions)
Figure 146. Novo Nordisk Insulin Market Share (2018-2020)
Figure 147. Eli Lilly Insulin Market Share (2018-2020)
Figure 148. Tonghua Dongbao Insulin Market Share (2018-2020)
Figure 149. Ganlee Insulin Market Share (2018-2020)
Figure 150. Sanofi-Aventis Insulin Market Share (2018-2020)
Figure 151. United Laboratory Insulin Market Share (2018-2020)
Figure 152. Jiangsu Wanbang Insulin Market Share (2018-2020)